相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Impact of Anticoagulation on Mortality and Resource Utilization Among Critically Ill Patients With Major Bleeding
Shannon M. Fernando et al.
CRITICAL CARE MEDICINE (2020)
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
Craig T. January et al.
CIRCULATION (2019)
Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors
S. J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Use of specific anti-Xa levels in acute kidney injury to transition patients from oral factor Xa inhibitors to i.v. heparin infusion
Sara Zochert et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2019)
Anticoagulation in chronic kidney disease: from guidelines to clinical practice
Viviana Aursulesei et al.
CLINICAL CARDIOLOGY (2019)
The efficacy and safety of direct oral anticoagulants in patients with chronic renal insufficiency: A review of the literature
Jacob Weber et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2019)
New Trends in Anticoagulation Therapy
Margaret Smith et al.
SURGICAL CLINICS OF NORTH AMERICA (2018)
A Multicenter Analysis of Factors Associated With Apixaban-Related Bleeding in Hospitalized Patients With End-Stage Renal Disease on Hemodialysis
Taylor D. Steuber et al.
ANNALS OF PHARMACOTHERAPY (2017)
Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end-stage renal disease on hemodialysis
Xiaoli Wang et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Discontinuation and Management of Direct-Acting Anticoagulants for Emergency Procedures
Jerrold H. Levy
AMERICAN JOURNAL OF MEDICINE (2016)
Antithrombotic Therapy for VTE Disease CHEST Guideline and Expert Panel Report
Clive Kearon et al.
CHEST (2016)
Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment
Allison E. Burnett et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2016)
Chromogenic laboratory assays to measure the factor Xa-inhibiting properties of apixaban-an oral, direct and selective factor Xa inhibitor
Richard C. Becker et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2011)
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor
Dagmar Kubitza et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Serial evaluation of the SOFA score to predict outcome in critically ill patients
FL Ferreira et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
分享论文
